The Chemistry of 7-OH

7-hydroxymitragynine (7-OH) is a potent substance derived from kratom that has become the focus of intense regulatory scrutiny. Proponents argue that it offers significant therapeutic potential and serves as a safer, more effective alternative for pain management and opioid withdrawal compared to the synthetic drugs often used in its place. The chemical process for its industrial production involves a precise extraction and oxidation method that converts mitragynine into 7-OH, a process detailed by the laboratory team in the footage. The regulatory environment surrounding 7-OH remains contentious, with the DEA moving towards scheduling it as a controlled substance despite arguments that it is not an opioid. Industry stakeholders and advocates feel this move is premature and potentially dangerous, suggesting that scheduling will drive users toward more harmful illicit substances. The controversy highlights a broader clash between public health advocacy and prohibitionist policy frameworks.